CARERATING1,697.20

CARE Ratings Limited

· Banking & Finance
₹ CrorePeersICRAMcap ₹5,100 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth+21.3+17.6
EBITDA Growth+38.5+27.1
EBIT Growth+41.3+27.4
Net Income Growth+36.5+24.1
EPS Growth+35.9+24.3
Total Assets Growth+13.8+15.3
Total Equity Growth+12.5+15.6
Cash from Operations Growth+35.3+20.1
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.